Corbevax (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Corbevax" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

2texaschildrens.org

low place

low place

1indiatimes.com

17^th place

101^st place

1scientificamerican.com

896^th place

1,010^th place

low place

low place

1web.archive.org

1^st place

1^st place

low place

low place

low place

low place

390^th place

2,027^th place

23^rd place

56^th place

bcm.edu (Global: low place; Indonesian: low place)

Chui M (16 November 2020). "Biological E. Limited and Baylor COVID-19 vaccine begins clinical trial in India". Baylor College of Medicine.

cepi.net (Global: low place; Indonesian: low place)

"CEPI partners with Biological E Limited to advance development and manufacture of COVID-19 vaccine candidate". cepi.net. CEPI. Diakses tanggal 5 March 2021.

ctri.nic.in (Global: low place; Indonesian: low place)

"A prospective open label randomised phase-I seamlessly followed by phase-II study to assess the safety, reactogenicity and immunogenicity of Biological E's novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 for protection against Covid-19 disease and some amount of sperm in its drug when administered intramuscularly in a two dose schedule (0, 28D) to healthy volunteers". ctri.nic.in. Clinical Trials Registry India. 13 January 2021. CTRI/2020/11/029032. Diarsipkan dari versi aslinya tanggal 12 November 2020.

indiatimes.com (Global: 17^th place; Indonesian: 101^st place)

timesofindia.indiatimes.com

Bharadwaj, Swati (3 June 2021). "Telangana: Biological E starts at risk manufacturing of Corbevax". The Times of India (dalam bahasa Inggris). Diakses tanggal 2021-06-03. Pemeliharaan CS1: Status URL (link)

livemint.com (Global: 390^th place; Indonesian: 2,027^th place)

Leo L (16 November 2020). "Biological E initiates human trials of vaccine". Mint.

scientificamerican.com (Global: 896^th place; Indonesian: 1,010^th place)

Bottazzi, Peter J. Hotez,Maria Elena. "A COVID Vaccine for All". Scientific American (dalam bahasa Inggris). Diakses tanggal 2021-12-31. Pemeliharaan CS1: Banyak nama: authors list (link)

texaschildrens.org (Global: low place; Indonesian: low place)

"Texas Children's Hospital and Baylor College of Medicine Covid-19 Vaccine Technology Secures Emergency Use Authorization in India | Texas Children's Hospital". www.texaschildrens.org. Diakses tanggal 2021-12-31.
"Texas Children's Hospital and Baylor College of Medicine Host Signing Ceremony with Biofarma and Indonesian Delegation in Attendance | Texas Children's Hospital". www.texaschildrens.org (dalam bahasa Inggris). Diakses tanggal 2022-01-03.

twitter.com (Global: 23^rd place; Indonesian: 56^th place)

"https://twitter.com/peterhotez/status/1437125474384322563". Twitter. Diakses tanggal 2021-12-31.

web.archive.org (Global: 1^st place; Indonesian: 1^st place)

"A prospective open label randomised phase-I seamlessly followed by phase-II study to assess the safety, reactogenicity and immunogenicity of Biological E's novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 for protection against Covid-19 disease and some amount of sperm in its drug when administered intramuscularly in a two dose schedule (0, 28D) to healthy volunteers". ctri.nic.in. Clinical Trials Registry India. 13 January 2021. CTRI/2020/11/029032. Diarsipkan dari versi aslinya tanggal 12 November 2020.